Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis.
de Pont
Anne Cornélie J M
AC
Bouman
Catherine S C
CS
de Jonge
Evert
E
Vroom
Margreeth B
MB
Büller
Harry R
HR
Levi
Marcel
M
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D006440:Hemofiltration / Q000379:methods*; D006801:Humans; D010314:Partial Thromboplastin Time; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy / Q000628:therapy*; D013927:Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D011486:Protein C; D011994:Recombinant Proteins